期刊文献+

补肾化痰祛瘀方治疗肥胖型多囊卵巢综合征35例临床观察 被引量:3

Tonifying kidney,resolving phlegm and removing blood stasis in treating 35 cases clinical observations of obesity-type polycystic ovary syndrome
下载PDF
导出
摘要 目的:观察自拟补肾化痰祛瘀方治疗肥胖型多囊卵巢综合征的疗效。方法:选取70例肥胖型多囊卵巢综合征患者作为研究对象,其中35例为治疗组,采用自拟补肾化痰祛瘀中药方治疗;35例为对照组,采用二甲双胍治疗,比较两组患者治疗3个月后在临床疗效、体重指数(BMI)、血清性激素(LH、FSH、T)、空腹血糖(FPG)、空腹胰岛素(FINS)、副作用等方面的差异。结果:两组总有效率比较,差异有统计学意义(P<0.05);治疗前后组内比较,所有观察指标均较治疗前明显改善(P<0.05);治疗后,两组组间比较,治疗组BMI、LH、FSH、T指标均较对照组有统计学差异(P<0.05)。结论:自拟补肾化痰祛瘀中药方治疗肥胖型多囊卵巢综合征疗效较好,能从整体上调节内分泌代谢,并且治疗中未出现不良反应,值得在临床推广运用。 Objective To observe the effect of self -prepared formula for tonifying kidney,resolving phlegm and removing blood stasis on obese polycystic ovary syndrome.Method Among 70 patients with obese polycystic ovary syndrome,35 cases were included in the treatment group,treated with self -prepared Chinese herbal formula for tonifying kidney,resolving phlegm and removing blood stasis;the other 35 cases were included in the control group,treated with Metformin.Compare the differences of the patients in the two groups in clinical efficacy,body mass index (BMI),serum sexual hormone (LH,FSH,T),fasting plasma glucose (FPG),fasting insulin (FINS),side effects after 3 -month treatment.Results Indicators were significantly lower in the treatment group after treat-ment (P 〈0.05),after treatment in the treatment group compared with the control group,differences in clinical efficacy,FSH (P 〈0.05),significant differences in terms of BMI,LH,T (P 〈0.05),FPG has no obvious difference (P 〉0.05),FINS after treatment there is no advantage in the treatment group,compared with the control group was not statistically significant.Conclusion Self -pre-pared Chinese herbal formula for tonifying kidney,resolving phlegm and removing blood stasis had a good efficacy in treating patients with obese polycystic ovary syndrome,and could regulate general endocrinological metabolism,without noticeable toxic or side effects, which is worth the promotion in clinical practice.
出处 《中国民族民间医药》 2015年第22期60-61,共2页 Chinese Journal of Ethnomedicine and Ethnopharmacy
关键词 肥胖型多囊卵巢综合症 自拟补肾化痰祛瘀方 临床观察 obese polycystic ovary syndrome self -prepared formula for tonifying kidney,resolving phlegm and removing blood stasis tonifying kidney,resolving phlegm and removing blood stasis Clinical curative effect
  • 相关文献

参考文献6

二级参考文献19

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3059
  • 2Wu XK,Zhou SY,Sallinen,et al.Ovarian selective resistance to insulin signaling in the polycystic ovary syndrome.Fertil Steril,2003,80(4):954~965.
  • 3Karen ER,Evelyn OT,Jeanne VZ,et al.Evidence for competing effects of body mass,hyperinsulinemia,insulin resistance,and androgen on leptin levels among lean,overweight and obese women with polycystic syndrome.Fertil Steril,2002,78(3):479~486.
  • 4Macial GA,Soares JM,Alves El,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.Fertil Steril,2004,81(2):355~360.
  • 5Glueck CJ,Goldenberg N,Pranikoff J,et al.Height,weight,and motor-social development during the first 18 months of lifes in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.Hum Reprod,2004,19(6):1323~1330.
  • 6Genazzani AD,Battaglia C,Malavasi B,et al.Metformin administration medolates and restore luteining hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.Fetil Steril,2004,81(1):114~119.
  • 7Gleuck CJ,Wang P,Fontaine R,et al.Metformin to Restore Normal Menses in Oligo-Amenorrheic Teenage Girls With Polycystic Ovary Syndrome (PCOS).J Adol Health,2001,29(3):160~169.
  • 8Kolodziejczyk B,Duleba AJ,Spaczynski RZ,et al.Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.Fertil Steril,2000,73(6):1149~1154.
  • 9Laure C,Morin-Papunen,Ilkka V,et al.Endocrine and metabolic effect of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome:a randomized study.J.Clin.Endocrinol.Metab,2000,85(9):3161~3168.
  • 10Morin-Papunen L,Vauhkonen I,Koivunen R,et al.Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome:a randomized study.J Clin.Endocrinol.Metab,2003,88(1):148~156.

共引文献370

同被引文献19

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部